Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase I/II Trial of UCB4594 in Participants With Advanced CancerAdnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, carcinoma, cervix disorder, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, epithelial neoplasm, esophageal disorder, female reproductive system disorder, female reproductive system neoplasm, gastric neoplasm, gonadal disorder, head and neck squamous cell carcinoma, intestinal disorder, lung disorder, lung neoplasm, malignant endocrine neoplasm, neoplasm, non-small cell lung carcinoma, ovarian cancer, ovarian disorder, pancreas disorder, pancreatic neoplasm, rectal disorder, respiratory system disorder, respiratory tract neoplasm, skin disorder, squamous cell carcinoma, stomach disorder, triple-negative breast carcinoma, uterine disorderRecruitingPhase 1 / Phase 22026-05-08NCT06380816

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Cancer Research UK59
UCB Biopharma SRL30

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Guy's HopsitalLondonUnited Kingdom2
The Christie NHS Foundation TrustManchesterUnited Kingdom40
The Newcastle upon Tyne Hospitals NHS Foundation TrustNewcastle upon TyneUnited Kingdom10
University Hospital Southampton NHS Foundation TrustSouthamptonUnited Kingdom24